Filter by
Dr. Feng Zhang nd his team were first to develop and demonstrate successful methods for using an engineered CRISPR-Cas9 system to edit genomes in living mouse and human cells
CURRENT ISSUE - April 2026
Why Performance, Cost, and Environmental Impact Now Compete in Procurement